AGGF1 Human Pre-designed siRNA Set A
AGGF1 Human Pre-designed siRNA Set A contains three designed siRNAs for AGGF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
AGGF1 Human Pre-designed siRNA Set A contains three designed siRNAs for AGGF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
AGGF1 siRNA-1: 5 nmol (HPLC)
AGGF1 siRNA-2: 5 nmol (HPLC)
AGGF1 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Gene ID
Gene Information
AGGF1 - angiogenic factor with G-patch and FHA domains 1 Gene (Human)
Also Known as
VG5Q; GPATC7; GPATCH7; HSU84971; HUS84971
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)